Related Experiment Video
Updated: May 9, 2026

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
Mitochondria-targeted antiaging gene therapy with adeno-associated viral vectors
1Department of Occupational Environmental Health, School of Public Health, Wuhan University, Wuhan, People's Republic of China.
Abstract:
Transgenic expression of catalase in mitochondria using a transgenic strategy extends life span and prevents aging-related pathology in mice. However, transgenic overexpression is not suitable for a clinical application. Adeno-associated virus (AAV) is the most promising gene delivery vehicle. Here we outline strategies on the generation of an AAV vector expressing the mitochondria-targeted catalase gene (AV.RSV.MCAT). We also describe methods for evaluating physiological impact of AV.RSV.MCAT on muscle contractility and running performance in mice.
Related Concept Videos
Gene Therapy
Gene Therapy
Mitochondria
Microorganisms in Medicine and Therapeutics
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Animal Mitochondrial Genetics
